Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

Colaboración

Año: 2017

Irigoyen, A; Gallego, J; Ponce, CG; Vera, R; Iranzo, V; Ales, I; Areevalo, S; Pisa, A; Martin, M; Salud, A; Falco, E; Saenz, A; Mozo, JLM; Pulido, G; Galaan, JM; Pazo-Cid, R; Rivera, F; Garcia, TG; Serra, O; Parra, EMF; Hurtado, A; Reina, MJG; Gomez, LJL; Esther, MOW; Benavides, M; Aranda, E

Título: EUROPEAN JOURNAL OF CANCER

• Q1